Vitrolife Interim Report January-March 2005
May 10, 2005 04:05 ET
|
Vitrolife
STOCKHOLM, Sweden, May 10, 2005 (PRIMEZONE) -- Vitrolife:
-- Sales increased by 3 percent, to SEK 30.5 (29.5) million. Adjusted
for exchange-rate effects the increase was 6 percent.
--...
Notice to attend the Annual General Meeting of Vitrolife AB
April 06, 2005 10:18 ET
|
Vitrolife
STOCKHOLM, Sweden, April 6, 2005 (PRIMEZONE) -- The shareholders of Vitrolife AB (publ) are hereby invited to the Annual General Meeting of shareholders on Tuesday May 10, 2005 at 5 pm on the...
Annual report 2004 Vitrolife AB (publ)
April 04, 2005 03:04 ET
|
Vitrolife
STOCKHOLM, Sweden, April 4, 2005 (PRIMEZONE) -- Vitrolife's annual report (in Swedish) has now been published and can be downloaded as a pdf file, either through the link below or from...
Report on Operations 2004: Vitrolife Doubles Operating Income
February 21, 2005 02:50 ET
|
Vitrolife
STOCKHOLM, Sweden, Feb. 21, 2005 (PRIMEZONE) -- Vitrolife:
- Sales increased by 8 percent, to SEK 103.9 (96.3) million. Adjusted for exchange-rate effects the increase was 11 percent. During the...
Vitrolife Obtains Patent in USA
February 15, 2005 05:54 ET
|
Vitrolife
STOCKHOLM, Sweden, Feb. 15, 2005 (PRIMEZONE) -- Vitrolife has been informed that the company's patent application regarding the use of alanyl-glutamine in media for in vitro fertilization has been...
Nominations Committee for Vitrolife AB (publ)
February 07, 2005 09:36 ET
|
Vitrolife
STOCKHOLM, Sweden, Feb. 07, 2005 (PRIMEZONE) -- The following people have been appointed as members of Vitrolife's nominations committee for the Annual General Meeting in 2005:
Carl Rosen,...
Vitrolife Receives Product Approval in USA
January 27, 2005 08:25 ET
|
Vitrolife
STOCKHOLM, Sweden, Jan. 27, 2005 (PRIMEZONE) -- Vitrolife has received sales approval from the Food and Drug Administration (FDA) to start marketing of its product ICSI(TM). The product is the first...
Vitrolife Interim Report January -- September 2004
October 28, 2004 07:58 ET
|
Vitrolife
STOCKHOLM, Sweden, Oct. 28, 2004 (PRIMEZONE) -- Vitrolife:
- Sales increased by 10 percent, to SEK 79.3 (72.3) million. Adjusted for exchange-rate effects the increase was 13 percent. During the...
Vitrolife Signs Research Agreement With Dr. Peter Svalander
October 20, 2004 08:58 ET
|
Vitrolife
STOCKHOLM, Sweden, Oct. 20, 2004 (PRIMEZONE) -- Vitrolife has signed a research agreement with Dr. Peter Svalander, the founder and former CEO of the company, regarding product development within the...
Vitrolife Strengthens Its Sales And Marketing Organization
October 08, 2004 09:48 ET
|
Vitrolife
STOCKHOLM, Sweden, Oct. 8, 2004 (PRIMEZONE) -- Vitrolife has strengthened its sales and marketing organization with Christer de Flon, the new sales director, and Roy Vallie, the new sales manager in...